UFC flyweight Alibi Idiris banned from MMA, win overturned after failed drug test

Alibi Idiris has accepted a 12-month ban for violating UFC Anti-Doping Policy.

The 10-1 flyweight rose to prominence during season 33 of The Ultimate Fighter last year.

Alibi Idiris made it all the way to the final before suffering an upset submission loss to Joseph Morales at UFC 319 in August.

Should Dana White permanently ban fighters for failing a drug test?

Let us know in the comments below where you stand on failed tests.

Alibi Idiris tested positive for hydrochlorothiazide

Alibi Idiris was given a shot in the UFC despite falling short in the Ultimate Fighter finale.

The 31-year-old squared off against flyweight veteran Ode Osbourne at UFC Houston in February.

Idiris won the fight by unanimous decision (29-28, 30-27, 30-27) – but the result has now been overturned to a no contest.

On Tuesday, the UFC announced Idiris had failed an in-competition test submitted to Combat Sports Anti-Doping (CSAD) on February 21.

The fighter from Kazakhstan was found to have hydrochlorothiazide, a prohibited diuretic in the Diuretics and Masking Agents class of substances on the UFC Prohibited List, in his system.

“Upon notification of this adverse finding, Idiris has been fully cooperative with CSAD,” the UFC statement said. 

Idiris provided information that he took a product that contained hydrochlorothiazide on Thursday of fight week to help him make the contracted weight on Friday, February 20, 2026, at the event’s official weigh-in. 

Although Idiris has been fully cooperative with CSAD, CSAD is not suspending or reducing any period of his ineligibility due to the seriousness of knowingly using a diuretic during fight week and the advantage that he received in making his contracted weight. 

“Idiris’s suspension began on February 21, 2026, the day he provided his adverse, in-competition biological sample.  His suspension will terminate on February 21, 2027.”